ERBB2 and lung carcinoma: Other experimental candidates include scFv, affibody and minibody (ERBB2/HER2 and FGFR1) [179–182], Protein–Fc (VEGFR1 and VEGFR2) [183] and Intact IgG (EGFR, ERBB2, and VEGF) in breast and lung cancer studies.